Medicapedia ESENCA
Image of Joseph L. Goldstein
Image: Wikimedia Commons

Joseph L. Goldstein

1940 · American biochemist and geneticist, Nobel laureate for his work on cholesterol

Share:FacebookWhatsApp

Joseph L. Goldstein (born April 18, 1940) is an American biochemist and geneticist who, together with Michael S. Brown, received the Nobel Prize in Physiology or Medicine in 1985 for their studies on cholesterol. Their work is a cornerstone for understanding how the body regulates the fats circulating in the blood and why an excess of them is linked to cardiovascular disease.

Goldstein studied at Washington and Lee University in Virginia and earned his medical degree at the University of Texas Southwestern Medical School. After his residency he worked at the National Institutes of Health in Bethesda, Maryland, in biochemical genetics. In 1972 he returned to the Southwestern Medical Center to head its division of medical genetics, and there began a long and close collaboration with Brown.

Together they studied familial hypercholesterolemia, an inherited condition in which blood cholesterol reaches very high levels from an early age. They found that human cells carry receptors on their surface that capture low-density lipoproteins (LDL), the so-called "bad" cholesterol, and remove them from circulation. When these receptors are scarce, cholesterol builds up in the blood and the risk of atherosclerosis, the progressive hardening and narrowing of the arteries, rises. Their findings laid the groundwork for the development of statin drugs.

In 1993 their trainees described the SREBP proteins, which regulate the production of cholesterol and fatty acids inside the cell nucleus. Goldstein has kept working directly in the laboratory, and his group has trained many scientists, several of whom have been elected to the US National Academy of Sciences. His legacy spans both pharmacology and the basic understanding of cellular metabolism.

Contributions

  • LDL receptor: a protein on the cell membrane that captures LDL cholesterol from the blood and removes it from circulation.
  • Familial hypercholesterolemia: an inherited disease they studied in depth, which helped them understand the role of these receptors.
  • SREBP proteins: membrane-bound transcription factors that switch on genes for cholesterol and fatty acid synthesis.
  • Statins: a family of drugs developed from their findings on cholesterol regulation.

Sources

Original Medicapedia text based on:

Last updated: 5 November 2026 · How Medicapedia is made

A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.